Experts call for stronger regulation of digital food marketing to counter the increasing risk for obesity and teens’ ...

Employers have the opportunity to lead by example: to stop treating obesity as invisible and start addressing it as the ...

The rise of GLP-1 agonist therapies has transformed obesity treatment, delivering unprecedented results and revealing their ...

Adults with obesity using a GLP-1 have a similar risk for obesity-related cancers as those who undergo bariatric surgery, researchers reported in data presented at the European Congress on Obesity and ...

Mitochondria play a central role in energy metabolism and overall health. In obesity and its comorbidities, mitochondrial ...

After years of easily available, cheap copies of Eli Lilly's and Novo Nordisk's highly effective weight-loss drugs, some U.S.

Health officials in Northern Ireland have given the go ahead for the first regional obesity management service.

A large European cohort study found that adherence to the Mediterranean diet mitigates the impact of genetic risk for obesity ...

GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl ...

Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...

Hundreds of thousands of people around the world are now on weight loss drugs like Wegovy, known as GLP-1s. The food industry is taking notice too, with big companies leaning into more nutritional ...

Researchers have discovered that tirzepatide and semaglutide impact energy metabolism in distinct ways. New animal research ...